Evidence map›Paper›PMID 37840845›Full record

ArticleGynecologic oncology reports2023

Secondary somatic glioblastoma arising from a mature ovarian cystic teratoma in a patient with underlying Li-Fraumeni syndrome.

Parker L Bussies, Danielle B Chau, Jonathan T Hunt, Maria Luisa C Policarpio-Nicolas, Cameron Friedman, Jesse K McKenney, Gabrielle A Yeaney, David M Peereboom, Lindsey Beffa

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Parker L BussiesWomen's Health Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Danielle B ChauWomen's Health Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Jonathan T HuntWomen's Health Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Maria Luisa C Policarpio-NicolasDepartment of Pathology, Cleveland Clinic Foundation, Cleveland, OH, United States.
Cameron FriedmanGenomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Jesse K McKenneyGenomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Gabrielle A YeaneyDepartment of Pathology, Cleveland Clinic Foundation, Cleveland, OH, United States.
David M PeereboomBrain Tumor and Neuro-Oncology Center, Cleveland Clinic Foundation, Cleveland, OH, United States.
Lindsey BeffaWomen's Health Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•First report of a secondary somatic glioblastoma arising from MCT-MT in a patient with underlying Li-Fraumeni syndrome.•The rarity of glioblastoma arising from MCT-MT warrants investigation for underlying genetic predisposition.•Glioblastomas arising from MCT-MT appear to exhibit wild type

Indexed as

Advanced-stage treatmentIDHLi-Fraumeni SyndromeMature ovarian cystic teratomaSecondary somatic glioblastomaTP53

Identifiers

PMID37840845
PMCPMC10570697
OpenAlexW4387036514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.